|
|
Volumn 92, Issue 23, 2000, Pages 1870-
|
|
Consensus panel endorses range of adjuvant therapies for breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
HORMONE;
HORMONE RECEPTOR;
PROTEIN P53;
TAMOXIFEN;
TAXANE DERIVATIVE;
TRASTUZUMAB;
AGED;
BREAST CANCER;
BREAST METASTASIS;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LABORATORY DIAGNOSIS;
MASTECTOMY;
MEDICAL DECISION MAKING;
MENOPAUSE;
MULTIMODALITY CANCER THERAPY;
NOTE;
ONCOGENE NEU;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RECURRENCE RISK;
TREATMENT PLANNING;
UNITED STATES;
|
|
EID: 0034614101
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.23.1870 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|